Human immunoglobulin for hepatitis B virus infection (Guangxi Beisheng Pharmaceutical)
人乙型肝炎免疫球蛋白（广西北生药业）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameHuman immunoglobulin for hepatitis B virus infection (Guangxi Beisheng Pharmaceutical)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2005/01/01
Country/Territory
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaWithdrawn
Originator CompaniesGuangxi Fortune Technology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesGuangxi Fortune Technology Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC Code
Related LinksN/A